High Point Advisor Group LLC Eli Lilly & CO Transaction History

High Point Advisor Group LLC

$1.4 Billion
Q1 2024

A detailed history of High Point Advisor Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, High Point Advisor Group LLC holds 17,136 shares of LLY stock, worth $15.5 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

17,136

Previous 16,946 1.12%

Holding current value

$15.5 Million

Previous $9.88 Million 34.96%

% of portfolio

0.95%

Previous 0.76%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $112,518 - $150,533	190 Added 1.12%	17,136 $13.3 Million
Q4 2023 Mar 26, 2024	BUY	$525.19 - $619.13 $2.82 Million - $3.32 Million	5,367 Added 46.35%	16,946 $9.88 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $164,171 - $192,762	589 Added 5.36%	11,579 $3.82 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $200,991 - $247,347	-907 Reduced 7.62%	10,990 $2.54 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $419,959 - $543,214	2,326 Added 24.3%	11,897 $2.73 Million

Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $112,723 - $145,925	686 Added 7.72%	9,571 $1.77 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $75,666 - $100,125	580 Added 6.98%	8,885 $1.79 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $47,521 - $54,967	-325 Reduced 3.77%	8,305 $1.21 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $26,738 - $32,179	-196 Reduced 2.22%	8,630 $1.41 Million
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $879,541 - $1.09 Million	7,388 Added 513.77%	8,826 $1.44 Million
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $925,494 - $1.15 Million	-7,774 Reduced 84.39%	1,438 $8.83 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $68,963 - $85,417	645 Added 7.53%	9,212 $1.3 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $103,159 - $112,210	966 Added 12.71%	8,567 $972,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $253,709 - $296,142	-2,290 Reduced 23.15%	7,601 $815,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $60,552 - $71,274	-544 Reduced 5.21%	9,891 $1.14 Million
Q4 2018 Feb 20, 2019	BUY	$105.9 - $118.64 $261,573 - $293,040	2,470 Added 31.01%	10,435 $1.27 Million
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $12,277 - $15,345	143 Added 1.83%	7,965 $892,000
Q2 2018 Aug 20, 2018	SELL	$75.7 - $86.88 $52,535 - $60,294	-694 Reduced 8.15%	7,822 $816,000
Q1 2018 Jun 11, 2018	BUY	$74.21 - $87.6 $30,871 - $36,441	416 Added 5.14%	8,516 $733,000
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $19,010 - $20,390	232 Added 2.95%	8,100 $617,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $606,386 - $673,028	7,868	7,868 $654,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Eli Lilly & CO Transaction History